Published in World J Surg on May 01, 2012
Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl (2014) 0.89
Outcome of patients undergoing right lobe living donor liver transplantation with small-for-size grafts. World J Gastroenterol (2014) 0.84
Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction. BMC Nephrol (2013) 0.81
Systems analysis of non-parenchymal cell modulation of liver repair across multiple regeneration modes. BMC Syst Biol (2015) 0.81
Nationwide longitudinal analysis of acute liver failure in taiwan. Medicine (Baltimore) (2014) 0.78
The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors. Transplant Direct (2016) 0.75
Systems Analysis of the Complement-Induced Priming Phase of Liver Regeneration. J Immunol (2016) 0.75
Application of elderly donor for liver transplantation. Int J Clin Exp Med (2015) 0.75
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature (2001) 6.95
Thrombotic microangiopathies. N Engl J Med (2002) 6.01
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem (2001) 3.02
The utility of marginal donors in liver transplantation. Liver Transpl (2003) 2.49
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl (2011) 2.22
Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood (1997) 2.12
A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem (2001) 1.67
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation (2003) 1.49
Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology (2010) 1.29
Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood (2002) 1.29
Liver regeneration in recipients and donors after transplantation. Lancet (1992) 1.15
Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl (2008) 1.13
Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res (2007) 1.10
Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg (2007) 1.09
Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl (2005) 1.07
Use of steatotic graft in living-donor liver transplantation. Transplantation (2003) 0.91
Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl (2008) 0.90
Augmentative effect of cyclosporin A on rat liver regeneration: influence on hepatocyte growth factor and transforming growth factor-beta(1). Eur Surg Res (1999) 0.90
The impact of donor age on living donor liver transplantation. Transplantation (2000) 0.90
Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation. Liver Transpl (2009) 0.89
Donor age in living donor liver transplantation. Transplant Proc (2008) 0.87
Postoperative liver regeneration and complication in live liver donor after partial hepatectomy for living donor liver transplantation. Yonsei Med J (2003) 0.87
Selective use of older adults in right lobe living donor liver transplantation. Am J Transplant (2007) 0.87
Donor outcome and liver regeneration after right-lobe graft donation. Transpl Int (2005) 0.85
von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population. J Thromb Haemost (2011) 0.84
Donor characteristics associated with liver graft survival. Transplantation (2005) 0.83
Donors older than 70 years in liver transplantation. Transplant Proc (2005) 0.81
Impact of age older than 60 years in living donor liver transplantation. Transplantation (2007) 0.81
Adult liver transplantation using liver grafts from donors over 70 years of age. Transplant Proc (2005) 0.81
Impact of cell cycle disruption on impaired hepatic regeneration in aged livers with ischemic insult. J Surg Res (2010) 0.80
Older donors: mounting risks for the hepatitis C-infected liver transplant recipient? Liver Transpl (2009) 0.79
Adult living donor liver transplantation using the right lobe. Transplant Proc (2006) 0.78
Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res (2009) 0.78
Impact of live donor age (>or=50) on liver transplantation. Transplant Proc (2007) 0.78
The impact of donor age on the outcome of adult living donor liver transplantation. Transplantation (2008) 0.78
Exaggerated up-regulation of tumor necrosis factor alpha-dependent apoptosis in the older mouse liver following reperfusion injury: targeting liver protective strategies to patient age. Liver Transpl (2009) 0.78
ADAMTS13 activity decreases after hepatectomy, reflecting a postoperative liver dysfunction. Hepatogastroenterology (2010) 0.78
The influence of donor age to graft volume increase rate in living donor liver transplantation. Transplant Proc (2001) 0.78
Impact of different cadaveric donor age cut-offs on adult recipient survival after liver transplantation: a single-center analysis. Transplant Proc (2005) 0.77
[Portal hemodynamic changes from partial hepatectomy--quantitative analysis of portal flow before, during and after hepatectomy, using an Doppler ultrasound system]. Nihon Shokakibyo Gakkai Zasshi (1990) 0.76
Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas (2004) 2.30
Brilliant blue G selectively stains the internal limiting membrane/brilliant blue G-assisted membrane peeling. Retina (2006) 2.14
Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura. J Allergy Clin Immunol (2013) 2.00
Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology (2008) 1.86
Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas (2004) 1.76
Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. Am J Hematol (2004) 1.55
Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost (2005) 1.55
Molecular diagnosis of prosthetic valve endocarditis with aorto-right atrial fistula. Int J Cardiol (2008) 1.46
Patients with a hypertensive response to exercise have impaired left ventricular diastolic function. Hypertens Res (2008) 1.45
Reduced Cd4+Cd25+ T cells in patients with idiopathic thrombocytopenic purpura. Thromb Res (2006) 1.42
Haemostatic abnormalities and thrombotic disorders in malignant lymphoma. Thromb Haemost (2005) 1.42
Impaired myocardial perfusion reserve in patients with fatty liver disease assessed by quantitative myocardial perfusion magnetic resonance imaging. Circ J (2012) 1.42
Molecular diagnosis of nonaneurysmal infectious aortitis. J Vasc Surg (2010) 1.42
Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Hum Pathol (2005) 1.41
JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg (2006) 1.39
Prognostic value of serum parathyroid hormone level in acute decompensated heart failure. Circ J (2014) 1.39
Retracted Positive feedback regulation between Akt2 and MyoD during muscle differentiation. Cloning of Akt2 promoter. J Biol Chem (2002) 1.28
JPN Guidelines for the management of acute pancreatitis: diagnostic criteria for acute pancreatitis. J Hepatobiliary Pancreat Surg (2006) 1.27
Current status of Japanese emergency medicine based on a cross-sectional survey of one prefecture. Emerg Med Australas (2007) 1.26
Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. JAMA (2007) 1.25
JPN Guidelines for the management of acute pancreatitis: cutting-edge information. J Hepatobiliary Pancreat Surg (2006) 1.21
Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy. J Hepatobiliary Pancreat Sci (2012) 1.20
A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res (2005) 1.18
Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol (2011) 1.18
K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transpl (2006) 1.17
Hepatoid adenocarcinoma of the stomach: histogenesis and progression in association with intestinal phenotype. Hum Pathol (2007) 1.15
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) (2010) 1.13
JPN Guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis. J Hepatobiliary Pancreat Surg (2006) 1.12
Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Shock (2009) 1.11
Ease of early gastric cancer demarcation recognition: a comparison of four magnifying endoscopy methods. J Gastroenterol Hepatol (2009) 1.11
Is early treatment of disseminated intravascular coagulation beneficial in septic patients? Crit Care (2014) 1.11
Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome. Mol Immunol (2013) 1.10
Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol (2002) 1.10
Factors that affect the surgical outcomes of spinal dural arteriovenous fistulas. Surg Neurol (2006) 1.09
Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population. Urology (2005) 1.08
Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost (2010) 1.07
Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl (2005) 1.07
JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg (2006) 1.05
A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes. J Leukoc Biol (2005) 1.04
Treatment strategy for acute pancreatitis. J Hepatobiliary Pancreat Sci (2009) 1.04
Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion (2002) 1.03
Laparoscopic splenectomy for a huge splenic cyst without preoperative drainage: report of a case. Surg Laparosc Endosc Percutan Tech (2003) 1.03
Reprogramming of human postmitotic neutrophils into macrophages by growth factors. Blood (2003) 1.03
Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol (2008) 1.03
Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol (2008) 1.02
Usefulness of breast-volume replacement using an inframammary adipofascial flap after breast-conservation therapy. Am J Surg (2007) 1.01
JPN Guidelines for the management of acute pancreatitis: treatment of gallstone-induced acute pancreatitis. J Hepatobiliary Pancreat Surg (2006) 1.01
Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematop (2011) 1.01
Development of mixed-type autoimmune hemolytic anemia and Evans' syndrome following chicken pox infection in a case of low-titer cold agglutinin disease. Int J Hematol (2006) 1.01
Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey. Thromb Res (2012) 1.00
Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery. Int J Hematol (2009) 1.00
Liver transplantation from donation after cardiac death: a single center experience. Transplantation (2007) 1.00
Notch ligand Delta-1 differentially modulates the effects of gp130 activation on interleukin-6 receptor alpha-positive and -negative human hematopoietic progenitors. Cancer Sci (2007) 0.99
Evaluation of new Japanese diagnostic criteria for disseminated intravascular coagulation in critically ill patients. Clin Appl Thromb Hemost (2005) 0.98
Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size. Lung Cancer (2010) 0.97
Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo. Mol Endocrinol (2010) 0.96
Prevalence and risk factors for knee osteoarthritis in elderly Japanese men and women. J Orthop Sci (2008) 0.96
Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese. Int Orthop (2010) 0.96
Identification of novel mutations in ADAMTS13 in an adult patient with congenital thrombotic thrombocytopenic purpura. Blood (2004) 0.96
Clinical significance of abnormal lipoprotein patterns in liver diseases. Int J Mol Med (2005) 0.96
Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol (2010) 0.95
The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol (2004) 0.95
Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int J Hematol (2014) 0.95
Therapeutic intervention and surgery of acute pancreatitis. J Hepatobiliary Pancreat Sci (2009) 0.95
Diagnosis of deep vein thrombosis by plasma-soluble fibrin or D-dimer. Am J Hematol (2005) 0.94
Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation. Liver Transpl (2013) 0.94
Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. J Hepatobiliary Pancreat Sci (2009) 0.93
Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma. BJU Int (2009) 0.93
Laparoscopic spleen-preserving pancreatic tail resection for an intrapancreatic accessory spleen mimicking a nonfunctioning endocrine tumor: report of a case. Surg Today (2004) 0.93
Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology (2007) 0.92
Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases. Thromb Res (2011) 0.91
Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation. Clin Appl Thromb Hemost (2003) 0.90
Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol (2007) 0.90
Refractory biliary leak from intrahepatic biliary-enteric anastomosis treated by selective portal vein embolization. J Vasc Interv Radiol (2002) 0.90
The clinical implication of 14-3-3 sigma expression in primary gastrointestinal malignancy. Int J Oncol (2004) 0.89
Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging (2008) 0.89
Surgical treatment of type IV choledochal cysts. J Hepatobiliary Pancreat Surg (2009) 0.89
Chromosomal aberrations and microsatellite instability of malignant peripheral nerve sheath tumors: a study of 10 tumors from nine patients. Cancer Genet Cytogenet (2006) 0.88
Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol (2007) 0.88